CollPlant Biotechnologies Ltd (CLGN) stock
CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
$3.96+0.06 (+1.54%)
Close on Nov 11, 2026Market cap $5.72MP/E –Yield –
CollPlant Biotechnologies free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$9.45M. The highest annual figure on record is $1.07M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.45M | – |
| FY2024 | Dec 31, 2024 | -$14.58M | – |
| FY2023 | Dec 31, 2023 | -$3.72M | – |
| FY2022 | Dec 31, 2022 | -$14.97M | -1495.3% |
| FY2021 | Dec 31, 2021 | $1.07M | – |
| FY2020 | Dec 31, 2020 | -$4.89M | – |
| FY2019 | Dec 31, 2019 | -$7.19M | – |
| FY2018 | Dec 31, 2018 | -$2.05M | – |
| FY2017 | Dec 31, 2017 | -$5.09M | – |
See a number that looks wrong?